Loading...

Loading...

Novo Nordisk Launches Wegovy Pill for Weight Management
By Sofía Garduño - Fri, 01/16/2026 - 10:14
Novo Nordisk launches Wegovy pill in the United States, introducing the first oral GLP-1 option for weight management.
https://mexicobusiness.news/tag/eli-lilly
More Health
Eli Lilly Becomes First Drugmaker to Reach US$1 Trillion in Value
By Sofía Garduño - Fri, 11/21/2025 - 12:32
Eli Lilly becomes the first drugmaker to hit US$1 trillion, driven by demand for obesity drugs and expectations for orforglipron’s approval next year.
Eli Lilly Becomes First Drugmaker to Reach US$1 Trillion in Value
By Sofía Garduño - Fri, 11/21/2025 - 11:55
Eli Lilly becomes the first drugmaker to hit US$1 trillion, driven by demand for obesity drugs and expectations for orforglipron’s approval next year.
Lilly Expands Access to Obesity Medicines Through US Agreement
By MBN Staff - Mon, 11/10/2025 - 11:12
Lilly partners with the US government to expand access to obesity drugs, reinforcing its long-term commitment to healthcare affordability.
Trump Unveils 100% Tariffs on Imported Pharmaceuticals
By Adriana Alarcón - Fri, 09/26/2025 - 11:00
Trump to impose 100% tariffs on pharma imports, sparking EU pushback and industry warnings over costs and supply chains.
Lilly’s Mounjaro Shows Effect in Pediatric Type 2 Diabetes Trial
By MBN Staff - Mon, 09/22/2025 - 17:11
Lilly reports that Mounjaro cut blood sugar and BMI in children with type 2 diabetes, marking a milestone in pediatric diabetes care.
Tirzepatide Prevents Major Cardiovascular Events: Eli Lilly
By MBN Staff - Mon, 08/18/2025 - 09:53
Eli Lilly reports that tirzepatide protects against adverse cardiovascular events, including cardiovascular death, myocardial infarction, or stroke.
UG Launches 3rd PSE Workshop to Boost Sustainable Production
By MBN Staff - Tue, 08/12/2025 - 09:50
UG launched the 3rd PSE Summer Workshop, uniting 100+ experts to advance cleaner, more sustainable production systems in Mexico.
Donanemab Gains EMA Panel Support for Alzheimer’s Treatment
By MBN Staff - Mon, 07/28/2025 - 08:59
Donanemab receives EMA panel’s recommendation for treating early Alzheimer’s, with implications for healthcare systems across the world.
AI in Biosciences, Vaccine Access, Tobacco: The Week in Health
By Sofía Garduño - Thu, 06/26/2025 - 10:00
OpenAI examined the role of AI in biosciences, Pfizer advanced efforts to expand vaccine access, and WHO renewed its call for tobacco control.